Quadratus Lumborum Block vs Tranversus Abdominis Plane Block for Cesarean Section
1 other identifier
interventional
76
1 country
1
Brief Summary
The Quadratus Lumborum block (QLB) was first described by Blanco in 2007. The main advantage of QLB compared to the Transversus Abdominis Plane block (TAP) is the extension of local anesthetic agent beyond the TAP plane to the thoracic paravertebral space. The wider spread of the local anesthetic agents may produce extensive analgesia and prolonged action of the injected local anesthetic solution. Previous studies showed that both TAP block and QLB may reduce morphine requirements in the postoperative period in patients who had cesarean section under spinal anaesthesia. However there are no published reports comparing the 2 techniques. The aim of this randomised controlled, double blinded study is to compare the analgesic efficacy of QLB compared to TAP block in patients who had cesarean section under spinal anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Jun 2015
Shorter than P25 for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 2, 2015
CompletedFirst Posted
Study publicly available on registry
July 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedMay 24, 2016
December 1, 2015
6 months
July 2, 2015
May 22, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Total morphine used in the first 48 hours after surgery
Total cumulative morphine dose in mg used in the first 48 hours after surgery
48 hours
Secondary Outcomes (3)
Severity of postoperative pain via visual analogue pain scale (VAS)
48 hours
Nausea or vomiting
48 hours
Sedation score
48 hours
Study Arms (2)
Quadratus Lumborum block group
ACTIVE COMPARATORQuadratus Lumborum block group (QL) patients will receive a bilateral Quadratus Lumborum block using Bupivicaine 0.125%
Transversus abdominis plane block group
ACTIVE COMPARATORTransversus abdominis plane block (TAP) patients will receive a bilateral TAP block using Bupivicaine 0.125%
Interventions
0.2 ml/kg bupivicaine 0.125% injected bilateraly at the posterior border of the quadratus Lumborum muscle
0.2 ml/kg bupivicaine 0.125% injected bilateraly between internal oblique and transversus abdominis muscles.
Eligibility Criteria
You may qualify if:
- Elective caesarean sections ASA 1 to 3 Written informed consent.
You may not qualify if:
- Patient refusal Local infection at the site of injection Allergy to study medications Sepsis Anatomic abnormalities Systemic anticoagulation or coagulopathy Inability to comprehend or participate in pain scoring system Inability to use intravenous patient controlled analgesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corniche Hospital
Abu Dhabi, 3788, United Arab Emirates
Related Publications (1)
Blanco R, Ansari T, Riad W, Shetty N. Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):757-762. doi: 10.1097/AAP.0000000000000495.
PMID: 27755488DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rafa Blanco, FRCA
Corniche Hospital
- PRINCIPAL INVESTIGATOR
Tarek Ansari, FFARCSI
Corniche Hospital
- PRINCIPAL INVESTIGATOR
Nanda Shetty, MD
Corniche Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2015
First Posted
July 3, 2015
Study Start
June 1, 2015
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
May 24, 2016
Record last verified: 2015-12